A discussion with Drs. Cumara O’Carroll, Mark Rubin, and Brian Chong reviewing recent trials demonstrating the clinical benefit of intra-arterial therapies in the management of acute stroke and how these trials could change acute management strategies and protocols.

Editor’s note: In this audio clip, Dr. Chong refers to vessel stenting as being discouraged in the the ESCAPE and REVASCATS trials; we would like to clarify that stenting was discouraged in ESCAPE but did occur in 9/19 cases in REVASCATS.

Click here to read the full article.